Schroder Investment Management Group’s Prestige Consumer Healthcare PBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
– Sell
-8,954
Closed -$561K – 1304
2022
Q4
$561K Sell
8,954
-4,383
-33% -$251K ﹤0.01% 1126
2022
Q3
$665K Sell
13,337
-10,773
-45% -$596K ﹤0.01% 1092
2022
Q2
$1.37M Sell
24,110
-3,303
-12% -$182K ﹤0.01% 1030
2022
Q1
$1.46M Sell
27,413
-2,517
-8% -$145K ﹤0.01% 1066
2021
Q4
$1.81M Hold
29,930
– – ﹤0.01% 948
2021
Q3
$1.68M Hold
29,930
– – ﹤0.01% 1015
2021
Q2
$1.56M Sell
29,930
-2,017
-6% -$96.9K ﹤0.01% 1066
2021
Q1
$1.41M Sell
31,947
-5,352
-14% -$225K ﹤0.01% 1079
2020
Q4
$1.3M Sell
37,299
-7,389
-17% -$262K ﹤0.01% 1079
2020
Q3
$1.6M Sell
44,688
-11,828
-21% -$440K ﹤0.01% 934
2020
Q2
$2.12M Buy
56,516
+11,239
+25% +$449K ﹤0.01% 813
2020
Q1
$1.77M Buy
+45,277
New +$1.76M ﹤0.01% 816

Other funds holding PBH

Schroder Investment Management Group's PBH Position: Q1 2023 in Review

Schroder Investment Management Group sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 8,954 shares — an estimated $561K sold.

Schroder Investment Management Group first reported a position in PBH in Q1 2020 and held it in 12 quarters. The position peaked at $2.12M in Q2 2020. 282 funds tracked by Wall St. Rank hold PBH as of Q1 2023.

  • Schroder Investment Management Group reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
  • Schroder Investment Management Group sold 8,954 Prestige Consumer Healthcare shares in Q1 2023, an estimated $561K.
  • Schroder Investment Management Group first reported a position in Prestige Consumer Healthcare in Q1 2020 and held it in 12 quarters.
  • Schroder Investment Management Group's Prestige Consumer Healthcare position peaked at $2.12M in Q2 2020.
  • 282 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.

Based on Schroder Investment Management Group's 13F filing for Q1 2023, filed 11 May 2023.